Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer: The ORIOLE Phase 2 Randomized Clinical Trial
JAMA Oncol 2020 Mar 26;[EPub Ahead of Print], R Phillips, WY Shi, M Deek, N Radwan, SJ Lim, ES Antonarakis, SP Rowe, AE Ross, MA Gorin, C Deville, SC Greco, H Wang, SR Denmeade, CJ Paller, S Dipasquale, TL DeWeese, DY Song, H Wang, MA Carducci, KJ Pienta, MG Pomper, AP Dicker, MA Eisenberger, AA Alizadeh, M Diehn, PT TranFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.